BUSINESS News 23andMe Lays Off 40% of Staff, Shuts Drug Development Business HS 11/11/2024 Advertisements The genetics company is closing a unit that was once seen as core to its future. Source link Continue Reading Previous Aristocrat to Sell Palarium Mobile Gaming for Up to $820 MillionNext Exxon Says Trump Should Keep U.S. in Paris Climate Pact More Stories BUSINESS News Paramount's hard-fought takeover of Warner Bros. Discovery closed Tuesday. Here's how we got here HS 06/10/2026 BUSINESS News Goldman: Diesel prices set to stay high through 2027 as refineries struggle to meet demand HS 06/10/2026 BUSINESS News World Bank warns of AI concentration risks as it lifts East Asia and Pacific growth outlook to 4.5% HS 05/10/2026